Stellate Ganglion Block
Recruiting · NCT06271707 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Minnesota
View the official record on ClinicalTrials.gov →Interventions studied
0.5% bupivacaineSaline
What this trial is about
The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
Who can take part
Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.
Exclusion criteria
- Patients who have an exclusion to regional anesthesia.
- Patients who have exclusion to stellate blockade.
- Patients who are pregnant assessed via self-report or pregnancy test if they have taken one
Where it is running
1 location listed across 1 US state.
- University of Minnesota - Minneapolis, Minnesota, United States